Depression Medication?

Back to Article
Back to Article

Depression Medication?

Hang on for a minute...we're trying to find some more stories you might like.


Email This Story






by Dillon Neely-Garcia

Depression is a leading mental disorder problem in the world. Many factors play into the cause of depression and it is hard to cure it. Many people try to hide their symptoms but the fact is that their problem is dangerous and can lead to a life of despair and death. But scientist have discovered and created a fast-acting depression drug in the form of a nasal spray.

On Tuesday, March 3rd, the Food and Drug  Administration approved this prescription to help the millions of Americans suffering this disease. The new drug, called Esketamine, is a newly formed nasal spray that was created by Janssen Pharmaceuticals, a branch of the Johnson and Johnson company. This drug will be under a shutter name (Spravato). The main ingredient is Ketamine, an active protein molecule that’s antidepressant properties are still being tested.

Spravato is a drug that will be provided to patients that have at least have tried two other drugs for depression but have shown no signs of progress. This means that only an estimated 6 million out of the 15 million depression-sufferers will have the chance to try this new drug. Spravato will not be administered to patients to take home but will be given at treatment centers. Each patient will be under surveillance while taking the nasal spray and will be given an amount that is believed to have no side-effects, but every drug has side effects and Spravato is no different. This drug can cause a decrease in attention, judgment, and the ability to think. Also, it can cause an increase in abuse and suicidal thoughts and behaviors. Also, Spravato is expensive at upwards of $500 per spray. This price will cause an average patient to spend upwards of $7,000. Doctors do believe that this drug will help with curing depression and hope that this drug will not become a failure.